- Home
- Automated
- List of product information
- IMDUR DURULES TABLET 60 MG [SIN01996P]
IMDUR DURULES TABLET 60 MG [SIN01996P]
Active ingredients: IMDUR DURULES TABLET 60 MG
Last updated 26 October 2025
On this page
Product Info
IMDUR DURULES TABLET 60 MG
[SIN01996P]
Product information
Active Ingredient and Strength | ISOSORBIDE-5-MONONITRATE - 60 MG |
Dosage Form | TABLET, FILM COATED |
Manufacturer and Country | ASTRAZENECA PHARMACEUTICAL CO. LTD - CHINA |
Registration Number | SIN01996P |
Licence Holder | ZUELLIG PHARMA PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | C01DA14 |
INDICATIONS
Imdur Durules are indicated for prophylactic treatment of angina pectoris.
Imdur Durules are not recommended for the management of acute attacks of angina pectoris (see PRECAUTIONS – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).
DOSAGE AND ADMINISTRATION
One 60 mg Imdur Durules once daily. The dose may be increased to 120 mg once daily.
Imdur Durules should not be administered twice daily.
If headache occurs, the initial dose may be reduced to half a 60 mg tablet daily until the headache disappears. Patients with severe renal impairment may require dosage reduction to half a tablet given once daily.
Imdur Durules should not be chewed or crushed, and should be swallowed whole with half a glass of fluid. If care is taken to avoid crushing or chewing the tablet, half doses of the 60 mg tablet may be administered without affecting the sustained-release properties of Imdur Durules.
CONTRAINDICATIONS
Known hypersensitivity to nitrates or to any of the components in Imdur, shock (including cardiogenic shock), hypotension, obstructive hypertrophic cardiomyopathy and pericarditis.
Phosphodiesterase type 5 Inhibitors (e.g. sildenafil, tadalafil and vardenafil) must not be given concomitantly with Imdur Durules.